| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 0% stake in Allena Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 0.6% stake in Jounce Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 8.1% stake in Jounce Therapeutics, Inc. |
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/23/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $7.005, valued at
$105.1k
|
|
| 11/19/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Sold 15,000 shares
@ $7.2515, valued at
$108.8k
|
|
| 11/13/2020 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/07/2018 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on MyoKardia Inc|
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G
| Third Rock Ventures II, L.P. reports a 13.5% stake in Allena Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 2.2% stake in Sage Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 6% stake in Blueprint Medicines Corporation |
| 02/13/2018 |
SC 13G
| Third Rock Ventures II, L.P. reports a 41.2% stake in Jounce Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| Third Rock Ventures II, L.P. reports a 0.7% stake in Global Blood Therapeutics, Inc. |
| 02/13/2018 |
4/A
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on MyoKardia Inc|
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
| 12/08/2017 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on MyoKardia Inc|
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
| 11/06/2017 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Allena Pharmaceuticals, Inc.|
Txns:
| Converted 2,575,964 shares
@ $0
Bought 215,000 shares
@ $14, valued at
$3M
Converted 6,122,448 preferred shares
@ $0
Converted 4,629,630 preferred shares
@ $0 |
|
| 11/01/2017 |
3
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 3 on Allena Pharmaceuticals, Inc. |
| 09/29/2017 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on MyoKardia Inc|
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
| 09/27/2017 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on MyoKardia Inc|
Txns:
| Sold 201,400 shares
@ $43, valued at
$8.7M
Sold 400,000 shares
@ $43, valued at
$17.2M
|
|
| 09/12/2017 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on MyoKardia Inc|
Txns:
| Sold 200,350 shares
@ $41, valued at
$8.2M
Sold 900 shares
@ $42.388, valued at
$38.1k
Sold 20,000 shares
@ $44.254, valued at
$885.1k
|
|
| 06/16/2017 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed of 1,000,000 shares
@ $0 |
|
| 04/06/2017 |
4
| Third Rock Ventures II, L.P. (10% Owner) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Disposed of 2,000,000 shares
@ $0 |
|
|